The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Share News (CLL)

  • There is currently no data for CLL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up UPDATE

Mon, 31st Mar 2014 10:41

African Minerals: Credit Suisse cuts target price from 280p to 200p maintaining a neutral rating.Anglo American: Credit Suisse reduces target price from 1900p to 1800p and retains an outperform rating.ARM Holdings: Barclays takes target price from 1125p to 1200p and reiterates an overweight recommendation.ASOS: Barclays increases target price from 6000p to 8000p, while its overweight rating remains unchanged.Berendsen: UBS raises target price from 950p to 1100p keeping a neutral rating.Cello Group: N+1 Singer lowers target price from 123p to 122p and retains a buy recommendation.Clinigen Group: Numis takes target price from 620p to 650p upgrading to buy.Daily Mail & General Trust: Westhouse Securities upgrades from neutral to add with a target price of 960p.Darty: N+1 Singer ups target price to 140p and upgrades to buy.easyJet: Numis raises target price from 1900p to 2100p upgrading to buy.Ferrexpo: Barclays shifts target price from 170p to 175p and keeps a neutral rating.Filtronic: Panmure Gordon reduces target price from 84p to 54p downgrading from buy to hold.Glencore Xstrata: Credit Suisse cuts target price from 400p to 380p and retains an outperform rating.Grainger: Jefferies ups target price from 239p to 260p and maintains a buy recommendation.ITE Group: Westhouse Securities cuts target price from 215p to 206p and maintains a neutral rating.Johnson Matthey: UBS raises target price from 3215p to 3275p and reiterates a neutral rating.London Mining: Credit Suisse cuts target price from 170p to 140p leaving its outperform rating unaltered.Majestic Wine: N+1 Singer cuts target price to 470p, while keeping its buy recommendation.Morrison (Wm): Societe Generale cuts target price from 200p to 170p and stays with its sell recommendation.Petards: Northland Capital reinitiates with a target price of 18p and a buy recommendation.Phoenix Group: canaccord Genuity cuts target price from 865p to 800p, while leaving its buy recommendation unchanged.Reckitt Benckiser: Deutsche Bank raises target price from 5100p to 6000p and retains its buy recommendation.Regenersis: Panmure Gordon places both its target price and its buy recommendation under review.Sage Group: Numis raises target price from 383p to 420p, while keeping its hold recommendation.Sainsbury: Societe Generale cuts target price from 370p to 330p reiterating its hold recommendation.Shanks Group: Investec downgrades from buy to add with a target price of 120p.Sportech: Panmure Gordon ups target price from 153p to 184p maintaining a buy recommendation.Travis Perkins: UBS moves target price from 2090p to 2100p and keeps a buy recommendation.Vedanta Resources: Credit Suisse cuts target price from 1270p to 1150p, while staying with its outperform rating.YouGov: Numis ups target price from 109p to 142p maintaining a buy recommendation.Zambeef: Panmure Gordon places both its target price (prev.: 28p) and its sell recommendation under review.
More News
18 Sep 2019 11:20

Cello Health reports positive momentum as it works on US market

(Sharecast News) - Healthcare-focussed advisory firm Cello Health reported a 6.8% improvement in net revenue to £54.5m in its half-year results on Wednesday, with its like-for-like constant currency net revenue growth standing at 4.5%.

Read more
18 Sep 2019 11:09

Cello Health Interim Profit Rises Sharply On Unit Performance

(Alliance News) - Cello Health PLC on Wednesday posted a markedly increased profit for the first half of 2019, pushed up by its Cello Health division.Shares in Cello were up 2.4% at 126.00

Read more
16 Aug 2019 10:45

Cello Health Acquires Innovative Science Solutions For USD11 Million

(Alliance News) - Healthcare advisory group Cello Health PLC said Friday it will acquire Innovative Science Solutions for up to USD10.5 million.ISS is a scientific consulting firm focused a

Read more
16 Aug 2019 07:57

Cello Health buys US-based scientific consulting firm ISS

(Sharecast News) - Healthcare-led advisory group Cello Health has announced the acquisition of Innovative Science Solutions (ISS), a US-based scientific consulting firm, for up to $10.5m.

Read more
18 Jul 2019 11:00

Cello Health Expects Like-For-Like Revenue Growth From First Half

(Alliance News) - Healthcare-focused advisory firm Cello Health PLC said on Thursday that it had a strong first half of the year, expecting like-for-like growth in net revenue and headline pretax

Read more
8 May 2019 10:38

Cello Health Expects Annual Result In Line Amid "Very Good" 2019 Start

LONDON (Alliance News) - The chair of healthcare advisory firm Cello Health PLC said Wednesday it expects its full-year results in line with expectations after a "very good" start to at

Read more
8 May 2019 10:37

Cello Health revenues and headline profits grow in Q1

(Sharecast News) - Healthcare-focused advisory group Cello Health saw like-for-like net revenue and headline pre-tax profits grow in the first quarter of its trading year, something it expects to carry over into the second quarter.

Read more
27 Mar 2019 14:04

FIL Lowers Cello Health Stake To Below 5% Notifiable Threshold (ALLISS)

LONDON (Alliance News) - Cello Health PLC on Wednesday said that FIL Ltd reduced its interest in the company to below the 5% notifiable threshold.Prior to Tuesday's deal, FIL held a in

Read more
21 Mar 2019 10:16

Cello Health Boosts Dividend As Lower Costs Lead To Profit Rise

LONDON (Alliance News) - Cello Health PLC on Thursday said its profit increased in 2018 due to a reduction in third party contract costs, while it has also hiked its dividend.Revenue for in

Read more
17 Jan 2019 13:21

Cello Health Trading In Line With Views Though Signal Business Slows

LONDON (Alliance News) - Cello Health PLC on Thursday said it is expecting results in line with market expectations despite slower client activity in the Cello Signal business.The marketing

Read more
17 Jan 2019 10:44

Cello Health sees strong like-for-like growth in 2018

(Sharecast News) - Healthcare-led advisory group Cello Health updated the market for the year ended 31 December on Thursday, reporting that it traded "well" in 2018, with continued strong like-for-like growth from Cello Health somewhat offset by a slower outcome from Cello Signal.

Read more
5 Nov 2018 14:35

Cello Health Promotes Director Chris Jones To Non-Executive Chairman

LONDON (Alliance News) - Healthcare-focused advisory group Cello Health PLC said Monday it has promoted Chris Jones to non-executive chairman with immediate effect, following the retirement of a a

Read more
10 Oct 2018 12:39

DIRECTOR DEALINGS: Cello Health Non-Executive Buys GBP30,000 In Shares

LONDON (Alliance News) - Cello Health PLC said Wednesday that Non-Executive Director Chris Jones bought shares in the company worth GBP29,998 worth of shares.Jones acquired 22,726 shares at

Read more
2 Oct 2018 11:11

Cello Health Promotes US Division CEO Ralston As Executive Director

LONDON (Alliance News) - Cello Health PLC said Tuesday it promoted Julia Ralston as executive director of the company with immediate effect.Ralston is currently the chief executive officer

Read more
19 Sep 2018 10:11

Cello Health Plans Expansion In US As Profit Increases In First-Half

LONDON (Alliance News) - Cello Health PLC on Wednesday said it plans further investments in developing its US business following profit growth in the first half of 2018.The advisory firm to

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.